COWN - コ―ウェン・グル―プ (Cowen Inc.) コ―ウェン・グル―プ



symbol COWN
会社名 Cowen Group Inc (コ―ウェン・グル―プ)
分野(sector) Finance   金融
産業(industry) Investment Bankers/Brokers/Service  
業種 投資銀行_証券サ―ビス   金融(Financials)
概要 事業概要 コーウェン(Cowen Inc.)(旧名:Cowen Group Inc.)は金融サービス会社である。同社は代替投資管理、投資銀行業務、研究、販売と取引、及びプライム・ブローカレッジ・サービスを提供する。同社は2つの事業を運営する。代替投資事業には、プライベート・エクイティ・ストラクチャ、登録済み投資会社及び上場投資ビークルが含まれる。ブローカー・ディーラー事業は、アドバイザリーとグローバル資本市場の創出とドメイン知識に基づく研究を含む成長を重視する企業向けの業界集中型投資銀行業務を提供し、機関投資家向けの販売・取引プラットフォームを提供する。ラミウスの名前で運営される代替投資プラットフォームは、機関投資家及び個人投資家向けの流動性スペクトラムを通じて投資商品とソリューションを提供する。ラミウスは投資家に、ロング/ショート・エクイティとイベント・ドリブン・エクイティを含む特定のニーズを満たす戦略へのアクセスを提供する。   コ―ウェン・グル―プは、米国の持株会社。子会社ラミナスを通じて、オルタナティブ投資、投資銀行業務、リサ―チ、セ―ルス・トレ―ディング業務等広範な金融サ―ビスを提供。ラミナス及びその関係会社がアルタナティブ投資を、コ―エン・アンド・カンパニ―及びその関係会社がブロ―カ―・ディ―ラ―業務を展開。   Cowen is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to its clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide.
本社所在地 599 Lexington Avenue New York NY 10022 USA
代表者氏名 Jeffrey M. Solomon ジェフリーM.ソロモン
代表者役職名 President Chief Executive Officer
電話番号 +1 212-845-7900
設立年月日 39965
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 769人
EBITDA EBITDA(百万ドル) -42.42900
終値(lastsale) 17.5
時価総額(marketcap) 518165760
時価総額 時価総額(百万ドル) 626.22510
売上高 売上高(百万ドル) 870.07100
企業価値(EV) 企業価値(EV)(百万ドル) 1454.6731
当期純利益 当期純利益(百万ドル) -9.24600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Cowen Inc revenues increased 76% to $486M. Net income applicable to common stockholders increased from $7M to $18.9M. Revenues reflect Alternative Investment Banking segment increase from $67M to $408.6M. Net income benefited from Restructuring costs decrease from $8.5M (expense) to $0K Net realized and unrealized gains (losse increase of 13% to $44M (income). Dividend per share totaled to $14.06.



   Sweetgreen headwinds challenge path to profitability argues Cowen By  2023/02/07 14:10:32
Sweetgreen headwinds challenge path to profitability argues Cowen
   Marinus Pharmaceuticals to Present at Upcoming Investor Conferences  2023/02/07 12:15:00 Wallstreet:Online
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present and participate during the following conferences in February and March. SVB Securities Global Biopharma Conference (virtual) February 15 at 2:20 p.m. E.T. Cowen 43rd
   Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters'' Option to Purchase Additional Shares in Public Offering of Class A Common Stock  2023/02/06 21:05:00 Benzinga
BRISBANE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQGM: VERA , "Vera")), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the closing of its previously announced underwritten public offering of 16,428,572 shares of its Class A common stock, including the exercise in full by the underwriters of their option to purchase an additional 2,142,857 shares, at a price to the public of $7.00 per share. The gross proceeds to Vera from the offering, before deducting underwriting discounts and commissions and offering expenses, are approximately $115.0 million. J.P. Morgan, Cowen and Evercore ISI acted as joint book-running managers for the offering. LifeSci Capital acted as lead manager for the offering. The offering was made pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was previously filed with the Securities and Exchange Commission (the "SEC") and was declared effective by the SEC on June 13, 2022.
   Cowen names this little-known defense systems stock a top pick, says it can rally 40%  2023/02/06 17:24:20 CNBC
Aerospace and defense company Moog is Cowen''s top small and medium-cap pick for 2023, calling it a transition story with 40% upside.
   Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock  2023/02/02 02:51:59 Benzinga
BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc., (NASDAQGM: VERA , "Vera")), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its previously announced underwritten public offering of 14,285,715 shares of its Class A common stock at a price to the public of $7.00 per share. The gross proceeds to Vera from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $100.0 million. In addition, Vera has granted the underwriters a 30-day option to purchase up to an additional 2,142,857 shares of Class A common stock at the public offering price less underwriting discounts and commissions. The offering is expected to close on February 6, 2023, subject to satisfaction of customary closing conditions. J.P. Morgan, Cowen and Evercore ISI are acting as joint book-running managers for the proposed offering.
   The Partner Companies Acquires UPG, a Leading Manufacturer of Highly-Engineered Components and Assemblies  2022/10/11 17:15:00 Accesswire
CHICAGO, IL / ACCESSWIRE / October 11, 2022 / The Partner Companies, LLC (TPC) announced today that it acquired the membership interest of UPG Company, LLC. from an affiliate of Turnspire Capital Partners, a New York private equity firm. UPG, based in Houston, is one of the world''s leading designers, manufacturers, and assemblers of mission critical components used in the medical, energy, and technology applications. Recognized by its global customers as an engineered solutions provider, UPG operates from three continents with facilities in the U.S., China, and the U.K. The company''s products include KVM rack-mounted console kits, drive carriers, monitors, and switches for data centers; ablation devices, surgical clips, and filters for the medical industry, and feedthroughs, perforation gun components, and boiler components for energy and industrial applications. Founded in 1954 in Anaheim, CA (and formerly known as Southern Plastic Mold), UPG''s heritage was built serving the computer equipment industry producing specialized composite parts.
   ''Market sees 60% chance Musk’s Twitter deal makes Oct 28 deadline''  2022/10/10 17:24:46 The Peninsula Qatar

The market is pricing in just a bit more than the odds of a coin toss that Elon Musk’s deal with Twitter Inc. will close by October 28, a court-issued deadline. That’s the calculation from Aaron Glick, a merger arbitrage strategist at Cowen Inc.

"Based on my informal survey last week, arbitrage traders tend to think Twitter’s price holds up well if we are going back to court,” Glick said. "The average guess of where Twitter trades if the deal is not consummated came out to around $45.”

With the Twitter shares trading on Monday at around $50.50, that near-term downside assumption puts the deal’s October closing probability at roughly 60%, he said, which is up from less than 50% as of Friday’s close. Cowen makes markets in, and is long equity options in, Twitter.

Twitter shares are up 2.

   Cowen Starts Third Harmonic Bio at Outperform  2022/10/10 09:48:01
   Third Harmonic Bio prices upsized IPO at $17 a share, midpoint of range  2022/09/15 11:58:20 MarketWatch
Third Harmonic Bio Inc. , a biotech specializing in allergic and inflammatory diseases, priced its initial public offering late Wednesday at $17 a share the midpoint of its $16 to $18 price range. But the company was able to upsize the deal to 10.9 million shares from an earlier plan to offer just 9 million. raising proceeds of $185.3 million. The stock will start trading later Thursday on Nasdaq under the ticker "THRD." Morgan Stanley, Jefferies and Cowen were joint bookrunners on the deal with LifeSci Capital acting as co-manager. The loss making company is still pre-revenue. The Renaissance Capital IPO ETF has fallen 43% in the year to date, while the S&P 500 has fallen 17%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.
   Cowen: Review Of The Toronto-Dominion Bank Acquisition (NASDAQ:COWN)  2022/09/12 07:48:03 Seeking Alpha
Cowen is financially strong and has a great track record of outperforming industry peers. Learn more about TD acquisition and why COWN stock is a Hold at the moment.
   Cowen expands digital assets team with key crypto-native hires  2022/08/25 19:44:43 CoinJournal
Cowen has hired former Head of Institutional Development Jackie Rose and ex-Coinbase VP… The post Cowen expands digital assets team with key crypto-native hires appeared first on CoinJournal .
   Investment Bank Cowen Nabs 2 Crypto Hires for Digital Asset Team  2022/08/25 11:00:00 CoinDesk
Cowen''s crypto-focused hires come after the bank launched its digital asset division this year.
   TD Bank Group Reports Third Quarter 2022 Results  2022/08/25 10:30:00 Benzinga
This quarterly Earnings News Release should be read in conjunction with the Bank''s unaudited third quarter 2022 Report to Shareholders for the three months ended July 31, 2022, prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), which is available on our website at . This analysis is dated August 24, 2022. Unless otherwise indicated, all amounts are expressed in Canadian dollars, and have been primarily derived from the Bank''s Annual or Interim Consolidated Financial Statements prepared in accordance with IFRS. Certain comparative amounts have been revised to conform to the presentation adopted in the current period. Additional information relating to the Bank is available on the Bank''s website at , as well as on SEDAR at and on the U.S. Securities and Exchange Commission''s (SEC) website at (EDGAR filers section).
   Cowen Continues to See Rising Product Costs for VF Corp.  2022/08/22 20:30:45
   Cowen on 22nd Century Group : ''GVB provides an attractive platform for XXII to build on its existing capabilities in cannabis''  2022/08/09 20:55:03

 関連キーワード  (投資銀行_証券サ―ビス 米国株 コ―ウェン・グル―プ COWN Cowen Inc.)


 twitter  (公式ツイッターやCEOツイッターなど)